BARCLAYS PLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 111 filers reported holding RECRO PHARMA INC in Q4 2019. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2021$5,000
-54.5%
2,606
-44.9%
0.00%
Q2 2021$11,000
-76.1%
4,728
-70.8%
0.00%
Q1 2021$46,000
+155.6%
16,203
+159.0%
0.00%
Q4 2020$18,0000.0%6,257
-29.8%
0.00%
Q3 2020$18,000
-62.5%
8,910
-16.6%
0.00%
Q2 2020$48,000
-22.6%
10,678
+43.4%
0.00%
Q1 2020$62,000
-87.2%
7,446
-71.8%
0.00%
Q4 2019$484,000
+143.2%
26,399
+47.0%
0.00%
Q3 2019$199,000
+3.1%
17,955
-5.2%
0.00%
Q2 2019$193,000
-38.5%
18,948
-64.6%
0.00%
Q1 2019$314,000
+5133.3%
53,562
+6645.8%
0.00%
Q4 2018$6,000
-88.5%
794
-89.1%
0.00%
Q3 2018$52,000
+333.3%
7,265
+231.9%
0.00%
Q2 2018$12,000
-78.2%
2,189
-56.0%
0.00%
Q1 2018$55,000
+129.2%
4,974
+90.6%
0.00%
Q4 2017$24,000
+380.0%
2,610
+342.4%
0.00%
Q3 2017$5,000
-66.7%
590
-71.7%
0.00%
Q2 2017$15,000
-87.2%
2,086
-84.4%
0.00%
Q1 2017$117,000
+550.0%
13,400
+488.2%
0.00%
Q4 2016$18,0002,2780.00%
Other shareholders
RECRO PHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders